Thomas A. Mace
Impact in
- Oncology top 2%
- Pancreatic and Hepatic Oncology Research
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- CAR-T cell therapy research
- Immunology top 2%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Phagocytosis and Immune Regulation
- Immunotherapy and Immune Responses
Papers in
- Oncology 27
- Pancreatic and Hepatic Oncology Research 15
- Cancer Immunotherapy and Biomarkers 12
- Cancer Cells and Metastasis 5
- Immunology 27
- Phagocytosis and Immune Regulation 11
- Immune cells in cancer 8
- Immune Cell Function and Interaction 7
- Co-authors
- Gregory B. Lesinski (32 shared papers)Mark Bloomston (8 shared papers)Elizabeth A. Repasky (8 shared papers)Gregory Young (16 shared papers)Tanios Bekaii‐Saab (15 shared papers)Chen-Ting Lee (3 shared papers)Lingwen Zhong (4 shared papers)Amy Collins (3 shared papers)
- Journals
- Cancer Research (7 papers)Journal for ImmunoTherapy of Cancer (7 papers)Cancer Immunology Immunotherapy (5 papers)Clinical Cancer Research (3 papers)Scientific Reports (3 papers)
- Partner nations
- United StatesUnited KingdomAustralia
In The Last Decade
Thomas A. Mace
61 papers receiving 2.5k citations
Thomas A. Mace's Hit Papers
Peers
Comparison fields: 5 of 118
- Oncology 1.3k
- Immunology 976
- Cancer Research 353
- Biotechnology 128
- Molecular Biology 777
Countries citing papers authored by Thomas A. Mace
This map shows the geographic impact of Thomas A. Mace's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas A. Mace with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas A. Mace more than expected).
Fields of papers citing papers by Thomas A. Mace
This network shows the impact of papers produced by Thomas A. Mace. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas A. Mace. The network helps show where Thomas A. Mace may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas A. Mace, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 64 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer Hit paper breakdown → | 2016 | 401 |
| 2 | 2013 | 344 | |
| 3 | 2016 | 119 | |
| 4 | 2017 | 114 | |
| 5 | 2019 | 113 | |
| 6 | 2013 | 81 | |
| 7 | 2012 | 78 | |
| 8 | 2011 | 77 | |
| 9 | 2010 | 75 | |
| 10 | 2014 | 71 | |
| 11 | 2015 | 70 | |
| 12 | 2012 | 70 | |
| 13 | 2015 | 69 | |
| 14 | 2017 | 63 | |
| 15 | 2012 | 62 | |
| 16 | 2020 | 61 | |
| 17 | 2017 | 55 | |
| 18 | 2019 | 54 | |
| 19 | 2013 | 51 | |
| 20 | 2011 | 40 |
About Thomas A. Mace
Thomas A. Mace is a scholar working on Oncology, Immunology, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 64 papers that have together received 2.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (15 papers), Cancer Immunotherapy and Biomarkers (12 papers), Phagocytosis and Immune Regulation (11 papers), Pancreatitis Pathology and Treatment (10 papers), Immune cells in cancer (8 papers), Immune Cell Function and Interaction (7 papers), Cancer Cells and Metastasis (5 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Oncology (1.3k citations), Immunology (976 citations), Cancer Research (353 citations), Biotechnology (128 citations) and Molecular Biology (777 citations). Thomas A. Mace has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Gregory B. Lesinski, Mark Bloomston, Elizabeth A. Repasky, Gregory Young, Tanios Bekaii‐Saab, Chen-Ting Lee, Lingwen Zhong, Amy Collins, Sylwia E. Wojcik and Zeenath Ameen. Their work appears in journals such as Cancer Research, Journal for ImmunoTherapy of Cancer, Cancer Immunology Immunotherapy, Clinical Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.